Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Wrapp

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Scientific Reports|October 26, 2018
Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysisRobert N Kirchdoerfer, Nianshuang Wang, Jesper Pallesen, et al.
Scientific Reports|December 12, 2018
Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysisRobert N Kirchdoerfer, Nianshuang Wang, Jesper Pallesen, et al.
Antibody Therapeutics|January 23, 2023
A novel humanized Chi3l1 blocking antibody attenuates acetaminophen-induced liver injury in miceLeike Li, Yankai Wen, Daniel Wrapp, et al.
Journal of Virology|September 22, 2023
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitopeRyan S McCool, Maryam Musayev, Sabrina M Bush, et al.
Journal of Virology|January 12, 2023
Structure-Based Stabilization of SOSIP Env Enhances Recombinant Ectodomain Durability and YieldDaniel Wrapp, Zekun Mu, Bhishem Thakur, et al.
Nature Communications|November 30, 2017
Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion stateIebe Rossey, Morgan S A Gilman, Stephanie C Kabeche, et al.
Nature Communications|February 15, 2017
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion stateIebe Rossey, Morgan S A Gilman, Stephanie C Kabeche, et al.
Immunity|February 4, 2018
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic HypermutationEileen Goodwin, Morgan S A Gilman, Daniel Wrapp, et al.
Cell|May 7, 2020
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid AntibodiesDaniel Wrapp, Dorien De Vlieger, Kizzmekia S Corbett, et al.
The Journal of Clinical Investigation|August 29, 2024
Discrimination of primary and chronic cytomegalovirus infection based on humoral immune profiles in pregnancyAndrew P Hederman, Christopher Al Remmel, Shilpee Sharma, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Scientific Reports|October 26, 2018
Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysisRobert N Kirchdoerfer, Nianshuang Wang, Jesper Pallesen, et al.
Scientific Reports|December 12, 2018
Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysisRobert N Kirchdoerfer, Nianshuang Wang, Jesper Pallesen, et al.
Antibody Therapeutics|January 23, 2023
A novel humanized Chi3l1 blocking antibody attenuates acetaminophen-induced liver injury in miceLeike Li, Yankai Wen, Daniel Wrapp, et al.
Journal of Virology|September 22, 2023
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitopeRyan S McCool, Maryam Musayev, Sabrina M Bush, et al.
Journal of Virology|January 12, 2023
Structure-Based Stabilization of SOSIP Env Enhances Recombinant Ectodomain Durability and YieldDaniel Wrapp, Zekun Mu, Bhishem Thakur, et al.
Nature Communications|November 30, 2017
Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion stateIebe Rossey, Morgan S A Gilman, Stephanie C Kabeche, et al.
Nature Communications|February 15, 2017
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion stateIebe Rossey, Morgan S A Gilman, Stephanie C Kabeche, et al.
Immunity|February 4, 2018
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic HypermutationEileen Goodwin, Morgan S A Gilman, Daniel Wrapp, et al.
Cell|May 7, 2020
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid AntibodiesDaniel Wrapp, Dorien De Vlieger, Kizzmekia S Corbett, et al.
The Journal of Clinical Investigation|August 29, 2024
Discrimination of primary and chronic cytomegalovirus infection based on humoral immune profiles in pregnancyAndrew P Hederman, Christopher Al Remmel, Shilpee Sharma, et al.
Pageof 7